About GeNouRoB
GeNouRoB is a company based in Laval (France) founded in 2007. GeNouRoB has raised $417.81 thousand across 4 funding rounds from investors including Siparex, GO CAPITAL and European Union. GeNouRoB offers products and services including GNRB, DYNEELAX, and SPINEO. GeNouRoB operates in a competitive market with competitors including Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.
- Headquarter Laval, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$417.81 K (USD)
in 4 rounds
-
Latest Funding Round
$55.05 K (USD), Grant
Nov 30, 2019
-
Investors
Siparex
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GeNouRoB
GeNouRoB offers a comprehensive portfolio of products and services, including GNRB, DYNEELAX, and SPINEO.
Device for automated knee laxity and ACL injury assessment.
Motorized tool for precise ligament analysis and diagnostics.
Patented device for spine therapy and back pain management.
Funding Insights of GeNouRoB
GeNouRoB has successfully raised a total of $417.81K across 4 strategic funding rounds. The most recent funding activity was a Grant round of $55.05 thousand completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $55,048
-
First Round
First Round
(01 Jun 2011)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Grant - GeNouRoB | Valuation |
investors |
|
| Jul, 2019 | Amount | Grant - GeNouRoB | Valuation |
investors |
|
| May, 2015 | Amount | Seed - GeNouRoB | Valuation |
investors |
Investors in GeNouRoB
GeNouRoB has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Siparex, GO CAPITAL and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Private equity investments are focused on growth stage companies.
|
Founded Year | Domain | Location | |
|
Private equity investments are directed toward multiple sectors.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GeNouRoB
Financial Statements - GeNouRoB
Genourob Comparisons
Competitors of GeNouRoB
GeNouRoB operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Needle-based visualization devices for orthopedic diagnostics are developed.
|
|
| domain | founded_year | HQ Location |
Digital depth gauges for orthopedic bone measurements are supplied.
|
|
| domain | founded_year | HQ Location |
Mini C-arms for orthopedic imaging are developed by OrthoScan.
|
|
| domain | founded_year | HQ Location |
MRI systems for extremity imaging are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Ultrasound-based POC device for osteoporosis screening is developed.
|
|
| domain | founded_year | HQ Location |
Robotic surgical systems for orthopedic treatments are provided.
|
Latest news on Genourob
Frequently Asked Questions about GeNouRoB
GeNouRoB was founded in 2007 and raised its 1st funding round 4 years after it was founded.
GeNouRoB is headquartered in Laval, France.
GeNouRoB is a funded company, having raised a total of $417.81K across 4 funding rounds to date.
Founded in 2007 in Laval, France, the company focuses on the medical devices sector. Devices and associated software are designed, produced, and marketed for assessing knee ligament structures and performance. Automated dynamic laximetry tools are utilized to measure laxity through standardized tests. Products are distributed in over 18 countries, supporting clinical evaluations and rehabilitation processes.
GeNouRoB's top competitors include Edge Surgical, Trice Medical and Echolight Medical.
GeNouRoB offers GNRB, DYNEELAX, and SPINEO.
GeNouRoB has 4 investors. Key investors include Siparex, GO CAPITAL, European Union, and EIC Fund.